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HLH: A rare association with LGL Leukemia 
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MD, Henry Kwang MD 
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Introduction 
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal syndrome characterized by excessive 
immune activation. It is diagnosed in patients of all ages and is classified as either primary from gene 
mutations or secondary from various triggers. We present an interesting case of HLH in a patient with 
large granular lymphocytic leukemia (LGL). 
 
Presentation 
A 53-year-old female with a questionable history of inflammatory osteoarthritis presented with fever and 
a diffuse papular erythematous rash. Her initial vital signs and labs were significant for temperature of 
102.7F, HR 116/min, WBC 14000/mcl, platelets 96000/mcl, ALT 198 U/L, AST 185 U/L, and total 
bilirubin 1.8 mg/dl. Given initial concerns for flea-borne disease, antibiotics were initiated without 
improvement. Infectious disease consult recommended broadening antibiotics, but patient continued to 
deteriorate and was noted to have progressive pancytopenia and an elevated ferritin of 1610 ng/ml.  
Given suspicion for a non-infectious process, hematologic workup was initiated. Peripheral smear showed 
an expanded population of CD8+ T-cell large granular lymphocytes. Hematology was consulted and 
confirmed diagnosis of LGL by flow cytometry. At this point, patient rapidly deteriorated and developed 
hallucinations, confusion, and lethargy. Patient was noted to have developed acute hyponatremia with 
sodium levels dropping by more than 10 over 1 day and urine studies and exam consistent with SIADH 
secondary to hematologic illness. Legionella and rickettsial disease panel were negative. MRI Brain was 
unremarkable, but lumbar puncture demonstrated an increased LGL population. Further workup revealed 
low fibrinogen of 124 mg/dl, elevated triglycerides of 296 mg/dl, extremely elevated IL-2 receptor alpha 
level (CD25) of 4667 U/ml (expected 223-710), and hepatosplenomegaly on abdominal CT. Bone 
marrow biopsy was normal. As patient met six of eight diagnostic criteria for HLH, she was started on 
treatment with dexamethasone along with hypertonic saline for acute SIADH with marked improvement 
of her clinical status over the next 3 days. The patient was subsequently discharged with prednisone with 
plans for outpatient hematology follow-up. 
 
Discussion 
HLH was historically described as a rare familial disorder of the young, but has increasingly been also 
recognized as an aggressive and potentially fatal syndrome in adults. Its presentation necessitates prompt 
hematologic evaluation and management. Limited literature has discussed the rare association of 
secondary HLH with LGL (<1% of cases), with our case demonstrating  rapid and drastic improvement 
with treatment of this unusual combination. Given its life-threatening nature, it is important for clinicians 
to consider HLH when dealing with a similar clinical scenario.  
 
 
 
